Rituximab ELISA (mAb-based)

Enzyme immunoassay for the specific and quantitative determination of free Rituximab (Rituxan®, Mabthera®) in serum and plasma.

The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Rituximab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.

Reference: IG-AB106

Barcode: 8699316552338

Legal Status: CE-Mark

Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

ig-ab106

Related Documents


Quality Control Certificates




Rituxan® and Mabthera® are trademarks of Biogen Idec/Genentech Inc.

The Kit at a glance:

ig-ab106

Required Volume (µL) 10
Incubation Time (min) 100
Sample Serum or Plasma
Package Size 96 Tests
Standard Range (ng/mL, 10x) 0-2000
Detection Limit (ng/mL) 5
Spike Recovery (%) >95
Shelf Life (years) 2

Standard Curve:

ig-ab106